- Senior Investigator, Infections and Immunoepidemiology Branch
Dr. Hildesheim was appointed Chief of the Infections and Immunoepidemiology Branch in 2008. He received his Ph.D. in epidemiology from The Johns Hopkins School of Hygiene and Public Health in 1991 and has been at the NCI since 1987. Dr. Hildesheim's research focuses on understanding host and viral factors involved in the pathogenesis of DNA virus-related tumors and in the evaluation of efficacy and underlying immunological mechanisms associated with licensed prophylactic HPV vaccines.
- (2020). Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. VACCINE. 38(38), 5997-6006.
- (2020). Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology. JOURNAL OF CLINICAL MICROBIOLOGY. 58(5),
- (2020). Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (vol 8, 5671, 2018). Scientific Reports. 10(1),
- (2020). The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 29(1), 57-62.
- (2019). Circulating Inflammation Markers and Risk of Gastric and Esophageal Cancers: A Case-Cohort Study Within the Japan Public Health Center-Based Prospective Study. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 28(4), 829-832.